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Abstract
Background: Statistical models of normal ageing brain tissue volumes may support earlier diagnosis of increasingly
common, yet still fatal, neurodegenerative diseases. For example, the statistically defined distribution of normal
ageing brain tissue volumes may be used as a reference to assess patient volumes. To date, such models were
often derived from mean values which were assumed to represent the distributions and boundaries, i.e. percentile
ranks, of brain tissue volume. Since it was previously unknown, the objective of the present study was to determine if
this assumption was robust, i.e. whether regression models derived from mean values accurately represented the
distributions and boundaries of brain tissue volume at older ages.
Materials and Methods: We acquired T1-w magnetic resonance (MR) brain images of 227 normal and 219
Alzheimer’s disease (AD) subjects (aged 55-89 years) from publicly available databanks. Using nonlinear regression
within both samples, we compared mean and percentile rank estimates of whole brain tissue volume by age.
Results: In both the normal and AD sample, mean regression estimates of brain tissue volume often did not
accurately represent percentile rank estimates (errors=-74% to 75%). In the normal sample, mean estimates
generally underestimated differences in brain volume at percentile ranks below the mean. Conversely, in the AD
sample, mean estimates generally underestimated differences in brain volume at percentile ranks above the mean.
Differences between ages at the 5th percentile rank of normal subjects were ~39% greater than mean differences in
the AD subjects.
Conclusions: While more data are required to make true population inferences, our results indicate that mean
regression estimates may not accurately represent the distributions of ageing brain tissue volumes. This suggests
that percentile rank estimates will be required to robustly define the limits of brain tissue volume in normal ageing and
neurodegenerative disease.
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Introduction
Methods to assist diagnosis and prediction of common, yet
still fatal, neurodegenerative diseases, such as Alzheimer’s
(AD), are urgently required as the number of these cases
becomes critical [1,2]. Statistical models of magnetic
resonance (MR) brain imaging data may provide such a
method. Specifically, models of normal brain volumes across
age may highlight incipient brain tissue loss due to AD and
other age-related neurodegenerative diseases [3,4]. These
models are often based on central tendency, e.g. mean or
median, statistical analyses. A semi-formal review (part of a
wider systematic review) found that, for over 20 years, mean-
based regression models have been used extensively to define
normal brain volumes across age (table 1) [5].
Mean estimates may be extrapolated to define clinical
distributions and boundaries if the variances in brain volume
are equally Gaussian between ages and disease states. If
variances are not equally Gaussian, the distributions and
boundaries of ageing brain volumes may not be well
represented by models based on mean estimates [6,7,8]. That
is, the true range of normality and boundaries with pathology
may be obscured if extrapolated from these models.
Several independent studies have shown that variance in
brain tissue volume is unequal between ages [3,9,10,11,12],
i.e. the range of volumes generally increases with age. This
inequality of variance was removed in previous ageing brain
image studies by performing data transformations, e.g. Box-
Cox [12,13]. While this approach is useful in research to
identify general patterns of brain ageing, it may obscure the
true limits of normality and the subtle early signs of disease.
We found no other previous study that attempted to define the
distributions and boundaries of brain volume between ages and
disease states. The true distributions of ageing brain tissue
volumes and the limits of normality are therefore largely
unknown.
Specifically, it is not known whether mean (parametric)
estimates of ageing brain volumes approximate percentile rank
estimates. In parametric regression models it is implicitly
assumed that mean estimates approximate percentile rank
estimates [6]. Percentile ranks are levels that represent
percentages of subjects within a distribution, e.g. the bottom
5% of subjects in a distribution have a value equal to or less
than the 5th percentile rank value [6]. To define these levels
with mean-based regression one must assume that differences
in brain tissue volume between ages are the same across all
percentile ranks. For example, it must be assumed that the
differences in brain tissue volume between 60 and 70 year olds
at lower ranks, e.g. the 5th percentile, are the same as the
differences between 60 and 70 year olds at higher ranks, e.g.
the 95th percentile. It is unknown whether or not this is true. If it
is not true then potentially important biological information may
be lost by extrapolation from mean-based regression. In
particular, the limits of normality and boundaries with pathology
may be misrepresented [6,8].
In this work, using publicly available brain images, we
attempted to determine whether mean regression estimates of
brain volumes across age approximated percentile rank
regression estimates. Our results show that, in presently
available data, mean estimates generally do not approximate
percentile rank estimates. We therefore suggest percentile rank
models will be required to robustly define the distributions and
limits of brain tissue volume in normal ageing and
neurodegenerative disease.
Materials and Methods
Subjects
This research used publicly available imaging data not
obtained at the authors’ institutions. All subjects in the Open
Access Series of Imaging Studies (OASIS; http://www.oasis-
brains.org/) participated in accordance with guidelines of the
Washington University Human Studies Committee. All subjects
Table 1. Methods to Define Normal Brain Volume across
Age.
Study
No. of
Subjects   
Age
rangea    
Mean ±SD
Agea   
Statistical
Methodb   
Allen et al., 2005 [26] 87 22.0–88.0 49.4 ±20.8
Multiple
regressionM
Courchesne et al.,
2000 [27] 116 1.6–80.0
21.4
±20.0
Regression
analysesM
DeCarli et al., 2005
[28] 2081 34.0–96.0
62.4
±10.4 Linear regression
M
Fotenos et al., 2005
[18] 94 65.0–95.0 78.0 ±8.0
Hierarchical
polynomial
regressionM
Ge et al., 2002 [9] 54 20.0–86.0 46.8±19.3
Least-squares
regressionM
Giorgio et al., 2010
[29] 66 23.0–81.6 36.7
c Regression
analysisM
Good et al., 2001
[30] 465 17.0–79.0 29.5
d General Linear
ModelM
Gur et al., 1991 [31] 69 18.0–80.0 41.4±20.2
Multivariate
analysis of
varianceM
Jernigan et al., 2001
[32] 78 30.0–99.0
64.0
±17.4
Nonparametric
monotone
regression
Kruggel, 2006 [12] 502 16.0–70.0 30.0 ±9.6 Linear, quadraticregressionM
Raz et al., 2005 [33] 72 20.0–77.0 52.6±14.1
Latent difference
modelM
Sowell et al., 2003
[34] 176 7.0–87.0
32.4
±21.8
Quadratic multiple
regressionM
Walhovd et al., 2005
[35] 25 67.0–88.0 74.3 ±4.8
Regression
analysesM
Ziegler et al., 2011
[36] 547 19.0–86.0
48.1
±16.6
General linear
modelM
Note: M=mean-based method; aIn years; bThis is the statistical method used to
provide the majority of results, recorded as stated in the corresponding manuscript;
cMedian; dEstimated median; SD=standard deviation.
doi: 10.1371/journal.pone.0084093.t001
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in the Alzheimer's Disease Neuroimaging Initiative (ADNI;
http://adni.loni.usc.edu/) provided written informed consent and
were recruited with respective institutional approval.
The ADNI, through collaboration among government, private,
and non-profit organizations (listed in the Financial Disclosure),
recruited subjects from over 50 sites across the United States
and Canada to test whether imaging and other biological
markers and clinical and neuropsychological assessment can
be combined to measure the progression and better treat mild
cognitive impairment (MCI) and early AD. For up-to-date
information, see www.adni-info.org.
MR brain images from 137 “normal” subjects (n=60, 44%
female), mean age ~76 (70-89) years, were acquired from the
ADNI databank (table 2). These subjects did not have
dementia, but potentially had non-debilitating conditions
common in ageing, e.g. hypertension. A further 90 subjects
(n=65, 72% female) with similar clinical characteristics and a
mean age of ~75 (60-89) years, were acquired from the OASIS
databank [14] (table 2). According to a recent systematic
review, ADNI and OASIS were the only public sources of
structural MR brain images that had medical and cognitive
metadata representative of the characteristics of normal older
people (≥60 years) [5]. These subjects were reported to be
representative of normal older people through cognitive and
physical tests but actual measures of potentially confounding
variables, e.g. blood pressure, were not available to us for all
subjects [14]. We combined the ADNI and OASIS samples to
create a single normal subject sample of n=227 subjects.
A sample of MR brain images from 124 subjects diagnosed
with AD (n=58, 47% female) and a mean age of ~75 (55-89)
years was also acquired from ADNI (table 2). A further 95 AD
subjects with similar demographics were acquired from OASIS
(table 2) and combined with the ADNI subjects to create a
single AD sample of n=219 subjects.
MR brain image acquisition and processing
In both ADNI and OASIS, 1.5 tesla (T) magnetization
prepared rapid gradient-echo (MP-RAGE) T1-weighted MR
brain images were acquired in the sagittal plane at
approximately 1x1x1mm resolution. The full acquisition
parameters are described elsewhere [14,15].
Non-brain structure was first removed from the images, by
the following steps
1. The Montreal Neurological Institute (MNI) 152 template
brain mask (http://www.bic.mni.mcgill.ca/ServicesAtlases/
HomePage) was fitted to each subject in two sub-steps
i. First, using Functional MRI of the Brain’s
(FMRIB’s) Linear Registration Tool (FLIRT) [16],
each subject was orientated to the position and
angle of the template
ii. Second, using Advanced Normalisation Tools
(ANTS) [17], the template was diffeomorphically
warped to approximate each subject’s anatomy.
2. The resulting brain mask of each subject was applied to
their FLIRT registered image to remove non-brain
structure.
3. The results of steps 1 and 2 were manually inspected by
slice and errors, e.g. remaining skull, corrected using the
Multi-image Analysis GUI (http://ric.uthscsa.edu/mango/
download.html).
To be consistent with previous studies [14,18], a bias field
correction was performed and grey matter (GM), white matter
(WM), and cerebrospinal spinal fluid (CSF) volumes were
calculated using FMRIB’s Automated Segmentation Tool
(FAST) [19]. The advanced age of these subjects meant that
many of them had what appeared to be WM lesions
(hypointense WM regions on T1-wieghted images that are
hyperintense on T2-weighted images). FAST sometimes
incorrectly classified these regions as GM. The MRI
sequences, e.g. fluid attenuated inversion recovery (FLAIR),
required to accurately address these errors were not available
for all subjects [14]. Although incorrectly classified as GM,
these regions were still correctly classified as tissue, i.e. not
CSF. We therefore added the GM and WM volumes within
each subject to calculate overall brain tissue volume in voxels.
Brain tissue volumes were then normalised (divided) by total
intracranial volume (TIV=tissue+CSF). We do not report
normalised CSF regression models because they were just the
exact inverse of normalised whole brain tissue volume models.
Calculating mean and percentile rank regression models
of brain volume by age.  When expressed in one year
Table 2. Demographics of the ADNI and OASIS subjects.
Sample Age in years No. of M:F (total)
ADNI   
Normal <70 0:0 (0)
 70–74 35:28 (63)
 75–79 25:22 (47)
 80–84 9:8 (17)
 85–89 8:2 (10)
 Overall 77:61 (137)
AD <70 16:12 (28)
 70–74 14:17 (31)
 75–79 12:14 (26)
 80–84 16:8 (24)
 85–89 8:7 (15)
 Overall 66:58 (124)
OASIS   
Normal <70 7:18 (25)
 70–74 7:19 (26)
 75–79 3:6 (9)
 80–84 4:13 (17)
 85–89 4:9 (13)
 Overall 26:72 (90)
AD <70 6:9 (15)
 70–74 10:15 (25)
 75–79 10:13 (23)
 80–84 10:15 (25)
 85–89 3:4 (7)
 Overall 39:56 (95)
Note: No.=number; M=males; F=females; ADNI=Alzheimer’s Disease
Neuroimaging Initiative; OASIS=Open Access Series of Imaging Studies.
doi: 10.1371/journal.pone.0084093.t002
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intervals, there were very few subjects at some ages. This
meant that it was not possible to calculate values of percentile
ranks at these ages. We therefore expressed age in the
following intervals: <70, 70-74, 75-79, 80-84, and 85-89 years.
Mean differences in brain tissue volume between age groups
were calculated in each sample with “PROC REG” in the
Statistical Analysis System (SAS) v9.3 (http://support.sas.com/
documentation/cdl/en/statug/63033/HTML/default/
viewer.htm#reg_toc.htm). PROC REG produces a regression
equation (y=βx1… βxn+c) to describe mean differences in a
dependent variable (y), e.g. brain tissue volume, between
values of independent variables (x1… xn), e.g. age group. The
beta (β) coefficients of this equation define the size of mean
differences between groups.
The 5th, 25th, 50th, 75th, and 95th percentile ranks of brain
tissue volume were directly calculated for each age group by
equation 1,
np= j+g (1.1)
y=1/2 x j+x j+1     if g=0 (1.2)
y= x j+1                    if g>0
where n is the number of subjects, for the tth percentile p=t/
100, j is the integer part of np, g is the fractional part of np, y is
the tth percentile, and x1, x2, ... , xn are the ordered values of
brain tissue volume. Differences in volume between ages
(regression equations) at these percentile ranks (rather than
the mean) were then calculated with PROC QUANTREG
(http://support.sas.com/documentation/cdl/en/statug/63033/
HTML/default/viewer.htm#statug_qreg_sect001.htm) in SAS.
For both mean and percentile rank estimates, we initially
performed linear regressions. These were used to produce
residual plots (actual minus regression predicted volumes by
age group). The linearity assumption is in question if these
plots show a systematic pattern, e.g. particular age groups with
skewed positive or negative residuals [6]. When the linearity
assumption was in question, we performed nonlinear (cubic)
regression to define differences between ages [18].
The representativeness of mean estimates was illustrated by
relative percent error between the expected (mean) and
observed (percentile rank) regression predictions, calculated by
equation 2,
y μp,i− y dp,i
Δμ
×100 (2)
where y μp,i is the mean-based prediction of percentile rank p
for age group i, y d p,iis the directly calculated percentile rank
prediction, and Δμ is the overall mean change in brain tissue
volume (mean regression predicted volume at <70 years minus
mean regression predicted volume at 85-89 years). Due to the
potential for subtle differences between ages and disease
[3,18], results are reported with four significant figures.
Results
Mean and variance of brain volume within the normal
and AD samples
The mean and standard deviation (SD) of normalised brain
volume in each age group in the normal and AD samples are
shown in table 3. Variance in brain tissue volume generally
increased with age in the normal sample but decreased with
age in the AD sample. Residual plots (actual minus regression
predicted volumes by age group) from the mean linear
regressions are shown in Figure 1. The different spread of
points at each age group further illustrates unequal variance
between ages. Moreover, skewed residuals at 70 years in the
normal sample (few positive compared to negative residuals)
and a similar pattern at 85-89 years in the AD sample
suggested that the linearity assumption was in question. We
therefore performed nonlinear regression of brain tissue
volume across age in each sample.
Mean and percentile rank regression estimates of brain
volume across age within the normal sample
Mean and percentile rank regression estimates of brain
volume across age in the normal sample are listed in table 4
and illustrated in figures 2 and 3. As the dashed (percentile
rank) lines within each graph are generally not parallel (Figure
2), the distribution of differences in brain tissue volume
between ages was not well represented by mean estimates.
The diverging percentile rank lines further illustrate that
variance in brain tissue volume increased with age in normal
subjects.
Mean estimates generally overestimated differences in brain
tissue volume between ages at percentile ranks above the
mean, i.e. in the upper percentile ranks, mean regression beta
underestimated brain tissue volume at advanced ages. For
example, the mean-based prediction of the 95th percentile of
brain volume at 85-89 years was short by 74% of the overall
expected change between <70 and 89 years (table 4). This is
in contrast to percentile ranks below the mean, where mean
Table 3. The mean and standard deviation of normalised
brain volume in each age group in the normal and AD
samples.
Sample Age n Mean SD
Normal <70 25 0.7555 0.0130
 70-74 89 0.7569 0.0196
 75-79 56 0.749 0.0204
 80-84 34 0.7418 0.0193
 85-89 23 0.73592 0.0210
AD <70 43 0.7399 0.0236
 70-74 56 0.7350 0.0208
 75-79 49 0.7330 0.0209
 80-84 49 0.7292 0.0199
 85-89 22 0.71285 0.0187
Note: SD=standard deviation.
doi: 10.1371/journal.pone.0084093.t003
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Figure 1.  Residual plots (actual minus mean linear regression predicted brain volumes by age) from the normal (top panel;
n=227) and AD (bottom panel; n=219) samples.  There are skewed residuals at 70 years in the normal sample (top) and a similar
pattern at 85-89 years in the AD sample (bottom). This means that the linearity assumption was in question.
doi: 10.1371/journal.pone.0084093.g001
Normal Ageing Brain Volume Variance and Limits
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estimates generally underestimated differences between ages,
i.e. in the lower percentile ranks, mean regression beta
overestimated brain tissue volume at advanced ages. For
example, the mean-based prediction of the 5th percentile of
brain volume at 85-89 years was inflated by 66% of the overall
expected change between <70 and 89 years (table 4).
Mean and percentile rank regression estimates of brain
volume across age within the AD sample
Mean and percentile rank regression estimates of brain
volume across age in the AD sample are listed in table 5 and
illustrated in Figure 4. As in normal subjects, the lack of parallel
lines (Figure 4) shows that the distribution of differences in
brain tissue volume between ages in AD was not well
represented by mean estimates. The converging percentile
rank lines further illustrate that variance in brain tissue volume
decreased with age in AD subjects.
Opposite to the normal sample, mean estimates generally
underestimated differences in brain tissue volume between
ages at percentile ranks above the mean, i.e. in the upper
percentile ranks, mean regression beta overestimated brain
tissue volume at advanced ages. For example, the mean-
based prediction of the 95th percentile of brain volume at 85-89
years was inflated by 47% of the overall expected change
between <70 and 89 years (table 5). This is in contrast to
percentile ranks below the mean, where mean estimates
generally overestimated differences between ages, i.e. in the
lower percentile ranks, mean regression beta underestimated
brain tissue volume at advanced ages. For example, the mean-
based prediction of the 5th percentile of brain volume at 85-89
Table 4. Mean and percentile rank regression estimates of normalised brain tissue volume by age in the normal sample.
Rank Age (x) c Beta_x Beta_x2 p prediction μ prediction (Δμ) % error
MEAN  0.7584 0.0007 -0.0011    
5th  0.7397 -0.0089 0.0002    
 <70 (1)    0.7310 0.7393 35
 70-74 (2)    0.7227 0.7367 59
 75-79 (3)    0.7148 0.7319 72
 80-84 (4)    0.7073 0.7249 75
 85-89 (5)    0.7002 0.7157 (0.0236) 66
25th  0.7545 -0.0049 -0.0002    
 <70 (1)    0.7494 0.7541 20
 70-74 (2)    0.7439 0.7515 32
 75-79 (3)    0.7380 0.7467 37
 80-84 (4)    0.7317 0.7397 34
 85-89 (5)    0.7250 0.7305 (0.0236) 23
50th  0.7533 0.0036 -0.0014    
 <70 (1)    0.7555 0.7529 -11
 70-74 (2)    0.7549 0.7503 -19
 75-79 (3)    0.7515 0.7455 -25
 80-84 (4)    0.7453 0.7385 -29
 85-89 (5)    0.7363 0.7293 (0.0236) -30
75th  0.7674 0.0038 -0.0016    
 <70 (1)    0.7696 0.7670 -11
 70-74 (2)    0.7686 0.7644 -18
 75-79 (3)    0.7644 0.7596 -20
 80-84 (4)    0.7570 0.7526 -19
 85-89 (5)    0.7464 0.7434 (0.0236) -13
95th  0.7747 0.0067 -0.0016    
 <70 (1)    0.7798 0.7743 -23
 70-74 (2)    0.7817 0.7717 -42
 75-79 (3)    0.7804 0.7669 -57
 80-84 (4)    0.7759 0.7599 -68
 85-89 (5)    0.7682 0.7507 (0.0236) -74
Note: This table shows the regression equations for the mean and each percentile rank. Percent errors between predictions are calculated for each age relative to the overall
mean regression change (Δμ=mean regression predicted volume at <70 years minus mean regression predicted volume at 85-89 years). Positive percent errors indicate that
the mean regression underestimated differences between ages, i.e. overestimated brain tissue volume at advanced ages. Negative percent errors indicate that the mean
regression overestimated differences between ages, i.e. underestimated brain tissue volume at advanced ages. Age groups were coded as 1 (<70) to 5 (85-89); c=intercept;
μ=mean; p=percentile rank.
doi: 10.1371/journal.pone.0084093.t004
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years was short by 28% of the overall expected change
between <70 and 89 years (table 5).
Comparison of normal and AD samples
There was increased overlap between normal and AD brain
tissue volumes with advancing age, as illustrated by the
diverging normal subject percentile ranks and converging AD
Figure 2.  Mean (top panel) and percentile rank (bottom panel) regression estimates of brain tissue volume across age in
the normal sample (n=227).  The slopes of these lines represent the beta coefficients in table 4. The mean-based model expects
all percentile ranks to change at the same rate, i.e. be parallel. The diverging percentile ranks show that this is not the case and that
variance in brain volume generally increased with age in the normal subjects. Although some may appear linear, each line is the
result of nonlinear regression (table 4).
doi: 10.1371/journal.pone.0084093.g002
Normal Ageing Brain Volume Variance and Limits
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subject percentile ranks (figures 2 and 4). Differences between
normal ageing subjects at lower percentile ranks were similar
to, or even greater than mean differences between AD
subjects. For example, 5th percentile rank differences in normal
subjects were 38.7% greater than mean differences in AD
subjects.
Discussion
We have shown in the publicly-available data that variances
in brain tissue volume are unequal across older ages. As a
result of this, the distributions and clinical limits of ageing brain
tissue volumes may not be well represented by mean
regression estimates. Differences in brain tissue volume
between normal subjects at the lowest percentile ranks (below
the mean) were considerably greater than differences at the
highest percentile ranks (above the mean). For example, mean
estimates inflated volumes by 35% to 75% at the 5th percentile
of normal subjects whereas they were short by 23% to 74% at
the 95th percentile of normal subjects. This normal variation
needs to be adequately defined so that it is not incorrectly
attributed to neurodegenerative disease. While we had
insufficient data to define true population distributions, this
proof of concept study suggests that percentile rank statistical
models will be required to do so.
Statistical models of the normal ageing brain may be used to
support earlier diagnoses of AD and related disorders
[3,20,21]. Models based on mean estimates found that
differences in brain tissue volume between ages were greater
in AD than in normal ageing [18]. These models assume that
the distributions of normal and AD brain volumes are equally
Gaussian within age, and that the overlap between these
distributions does not change with age [6]. We found that the
distributions of brain volume were not equal within age and that
the overlap between normal and AD brain volumes increased
with advancing age. Further, we found that differences in brain
tissue volume between normal ageing subjects at lower
percentile ranks may be similar to, or even greater than
differences between patients diagnosed with AD. Therefore, if
a group of subjects acquired for controls in a clinical trial was
unknowingly skewed to lower percentiles, true treatment effects
in brain volume between normal ageing and AD may be
obscured.
A percentile rank-based reference for brain volumes may
then be useful to quantitatively rank individuals or to determine
if the distribution of a control group is skewed. Given the wide
and irregular variance in brain volume that we have identified in
a relatively small number of apparently normal subjects, this
percentile rank-based reference will require much more data
than are publicly available at present [5].
New databanks such as Minimal Interval Resonance Imaging
in Alzheimer's Disease (MIRIAD), which provides longitudinal
data from 23 cognitively tested normal ageing subjects [22],
may help to address this shortage. The Australian Imaging
Biomarkers & Lifestyle Flagship Study of Ageing (AIBL)
databank is similar to ADNI and OASIS and includes 177
control subjects aged over 60 years. However, these subjects
are not generally representative of the normal ageing
population as they were preferentially selected as APOE ε4
allele carriers [23].
Other neuroimaging databank projects are ongoing or
initiating that may, in due course, provide the required data. For
example, we are building a brain image databank and
reference atlas using existing data from >1000 cognitively
Figure 3.  Illustration of the varying differences in normal ageing brain tissue volume, according to percentile rank.  There
were much greater differences between ages at the 5th percentile of brain tissue volume (bottom panel) than between ages at the
95th percentile (top panel) of normal subjects.
doi: 10.1371/journal.pone.0084093.g003
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tested normal subjects aged mostly between 55 and >90 years
(http://www.sinapse.ac.uk/research-resources/brains-project).
These data are in the process of being collated and were not
available at the time of this study. In the future, by iteratively
adding subjects and monitoring subsequent fluctuations in
percentile rank values, we may determine the amount of data
required to create robust models of brain tissue volume in
normal ageing and neurodegenerative disease.
The limited number of subjects available to the present study
(n=446) meant that we had to express age in five year rather
than one year intervals. Differences between subjects within
these intervals could not then be calculated here but could be
calculated in future studies with larger samples. The age
groups in this study did not have equal sample sizes and this
may have contributed to unequal variance in brain volume [6].
Sample size generally decreased while variance increased with
age in the normal subjects. Since a larger number of subjects
generally leads to greater variance [6], inequality of variance
may actually be even greater in future studies with more
subjects. This further suggests that percentile rank models will
be required to adequately describe the true levels and limits of
ageing brain volumes.
The inclusion of “normal” subjects with and without
hypertension or other risk factors may have also contributed to
the unequal variance in brain tissue volume. We could not
specifically test this here as, although assessed by ADNI and
OASIS, the actual measures of risk factors for all subjects were
not available to us. Regardless of this, as at least 50% of
subjects tend to be diagnosed with hypertension in many
“normal” older cohorts [24], it could be argued that the inclusion
of subjects with and without hypertension is more
representative of the normal ageing population.
Table 5. Mean and percentile rank regression estimates of normalised brain tissue volume by age in the AD sample.
Rank Age (x) c Beta_x Beta_x2 p prediction μ prediction (Δμ) % error
MEAN  0.73638 0.0035 -0.0015    
5th  0.6950 0.0072 -0.0020    
 <70 (1)    0.7002 0.6970 -14
 70-74 (2)    0.7014 0.6960 -24
 75-79 (3)    0.6986 0.6920 -30
 80-84 (4)    0.6918 0.6849 -31
 85-89 (5)    0.6810 0.6749 (0.0222) -28
25th  0.7186 0.0062 -0.0019    
 <70 (1)    0.7229 0.7206 -10
 70-74 (2)    0.7234 0.7196 -17
 75-79 (3)    0.7201 0.7156 -20
 80-84 (4)    0.7130 0.7085 -20
 85-89 (5)    0.7021 0.6985 (0.0222) -16
50th  0.7474 -0.0060 0.0000    
 <70 (1)    0.7414 0.7494 36
 70-74 (2)    0.7354 0.7484 59
 75-79 (3)    0.7294 0.7444 68
 80-84 (4)    0.7234 0.7373 63
 85-89 (5)    0.7174 0.7273 (0.0222) 44
75th  0.7399 0.0098 -0.0025    
 <70 (1)    0.7472 0.7419 -24
 70-74 (2)    0.7495 0.7409 -39
 75-79 (3)    0.7468 0.7369 -45
 80-84 (4)    0.7391 0.7298 -42
 85-89 (5)    0.7264 0.7198 (0.0222) -30
95th  0.7794 -0.0016 -0.0009    
 <70 (1)    0.7769 0.7814 20
 70-74 (2)    0.7726 0.7804 35
 75-79 (3)    0.7665 0.7764 45
 80-84 (4)    0.7586 0.7693 48
 85-89 (5)    0.7489 0.7593 (0.0222) 47
Note: This table shows the regression equations for the mean and each percentile rank. Percent errors between predictions are calculated for each age relative to the overall
mean regression change (Δμ=mean regression predicted volume at <70 years minus mean regression predicted volume at 85-89 years). Positive percent errors indicate that
the mean regression underestimated differences between ages, i.e. overestimated brain tissue volume at advanced ages. Negative percent errors indicate that the mean
regression overestimated differences between ages, i.e. underestimated brain tissue volume at advanced ages. Age groups were coded as 1 (<70) to 5 (85-89); c=intercept;
μ=mean; p=percentile rank.
doi: 10.1371/journal.pone.0084093.t005
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The incidence of normal subjects with silent AD pathology
(e.g. that might be detected with Pittsburgh Compound-B (PIB)
binding) or cognitive decline that has not yet reached the point
of dementia, may also partially explain the increasing variance
in brain volume with age. These data were not available for all
subjects and therefore a bias would have been introduced had
we excluded only some subjects based on these measures.
Further, it was not the aim of this study to determine the
Figure 4.  Mean (top panel) and percentile rank (bottom panel) regression estimates of brain tissue volume across age in
the AD sample (n=219).  The slopes of these lines represent the beta coefficients in table 5. The mean-based model expects all
percentile ranks to change at the same rate, i.e. be parallel. The converging percentile ranks show that this is not the case and
variance in brain volume generally decreased with age in the AD subjects. Although some may appear linear, each line is the result
of nonlinear regression (table 5).
doi: 10.1371/journal.pone.0084093.g004
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sources of normal ageing brain volume variance but to
demonstrate the effect of this variance. A longitudinal study
with these imaging and risk factor measures will be required to
determine true population distributions and the sources of
variance in normal ageing brain volumes.
Although all subjects were scanned with the same T1 MP-
RAGE sequence, the different scanners used in ADNI may
have also affected variance in brain volume [25]. However, all
scanner protocols were standardised [15] and the magnitude of
difference between brains that we detected is too large to be
attributed only to differences in scanner performance. Indeed,
studies using one scanner and equally sized age groups [3]
have shown that irregular variance in brain tissue volume is
attributable to advancing age.
Our calculation of TIV will have underestimated true TIV
because the venous sinuses as well as CSF expand to occupy
space vacated by the shrinking brain [24]. Further, FMRIB’s
FAST may have incorrectly classified hypointense areas of WM
on MP-RAGE (potentially WM lesions) as GM. The MRI
sequences, e.g. FLAIR, required to correct these errors were
not available for all subjects [14]. These regions were still
correctly classified as tissue, i.e. not CSF, and so we combined
GM and WM volumes to calculate whole brain tissue volume
for each subject. Future studies and brain image databanks will
need to acquire additional sequences, such as FLAIR, for more
accurate calculations of brain and specific tissue, i.e. GM vs.
WM, volumes.
Percentile rank brain volume models may provide at least
two novel benefits. The first is that, given the general
association between brain volume and cognitive function [18],
percentile ranks may provide a measure to predict future brain
loss and cognitive decline in individual patients. For example,
normal subjects at the lowest percentile ranks may be at
greater risk of developing cognitive decline and dementia. We
will test this in a planned longitudinal study. The second benefit
is that percentile ranks provide more detailed descriptions of
the differences between normal and diseased groups. That is,
they show whether general (mean) differences are due to
consistent differences between subject groups or whether one
group has a skewed distribution of brain structure, e.g. a
proportion of subjects with extremely low values of brain
volume. These benefits suggest that percentile rank models
may ultimately provide deeper understanding of brain volume
changes in normal ageing and, in future, assist diagnoses of
neurodegenerative disease.
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